Summary Takeda Pharmaceuticals International GmbH (Takeda Pharmaceutical International) formerly Nycomed International Management GmbH (Nycomed) is a pharmaceutical company and wholly owned subsidiary...
Summary Takeda Pharmaceutical Company Limited (Takeda) is a pharmaceutical company. The company focuses on the manufacture of ethical drugs and consumer health care products. It manufactures and markets...
The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector This report presents leading...
This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area It makes a wide-ranging assessment of the...
Global Pharmaceuticals and biotechnology outlook - Japan Pharma The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi...
This analysis examines the historical and forecast performance for Takeda in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis...
Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...
“Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential ” provides key data, information and analysis on the key lifecycle management strategies implemented by pharmaceutical...
The successful introduction of orphan products in Europe remains problematic for the developers, although they can seek to alleviate some of the issues by carefully developing a launch strategy The...
Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Ulcerative Colitis Therapeutics...
Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains...
To improve R&D productivity and curtail expenses, pharmaceutical companies are downsizing and strategically outsourcing operations, in-licensing from small innovators, investing in IT automation, and...
Introduction The failure of obesity therapies to meet US FDA safety demands has resulted in a series of negative regulatory responses and has prevented new approvals in obesity. This has left Xenical...
Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides...
Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Orteronel (Prostate Cancer) - Forecast and Market Analysis...
Allergic Rhinitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Allergic Rhinitis Therapeutics...
This report analyzes the worldwide markets for DPP-IV Inhibitors in US$ Million by the following drugs – Sitagliptin, Vildagliptin, Saxagliptin, and Other DPP-IV Inhibitors (including Linagliptin and...
Summary Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies. It undertakes the research, development, manufacture and commercialization of a wide range of pharmaceuticals....
Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Basen (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Basen sales estimates for...
Summary Celgene Corporation (Celgene) is a biopharmaceutical company. It carries out the research, development, manufacture, and marketing of therapies designed to treat cancer and immune-inflammatory-related...
